BCL2L11 Gene

BCL2L11 Gene

Pathway Diagram

```mermaid
flowchart TD
FOXO["FOXO<br/>Transcription Factor"] -->|"activates"| BCL2L11["BCL2L11 (BIM)<br/>Pro-apoptotic Protein"]

BCL2L11 --> Apoptosis["Neuronal Apoptosis<br/>Cell Death"]

PTEN["PTEN<br/>Tumor Suppressor"] -->|"interacts_with"| BCL2L11
MAPK8["MAPK8 (JNK)<br/>Stress Kinase"] -->|"activates"| BCL2L11

BCL2L11 -->|"interacts_with"| BNIP3["BNIP3<br/>Mitochondrial Death Protein"]
BCL2L11 -->|"interacts_with"| CHOP["CHOP/DDIT3<br/>ER Stress Response"]

ER_Stress["ER Stress<br/>Protein Misfolding"] --> CHOP
Oxidative_Stress["Oxidative Stress<br/>ROS Production"] --> MAPK8

BCL2L11 -->|"interacts_with"| DRP1["DRP1<br/>Mitochondrial Fission"]
DRP1 --> Mito_Dysfunction["Mitochondrial<br/>Dysfunction"]

BCL2L11 -->|"interacts_with"| BECN1["BECN1<br/>Autophagy Regulator"]
BECN1 --> Autophagy["Impaired Autophagy<br/>Protein Clearance"]

Apoptosis --> Alzheimer["Alzheimer's<br/>Disease"]
Apoptosis --> Parkinson["Parkinson's<br/>Disease"]
Apoptosis --> ALS["Amyotrophic Lateral<br/>Sclerosis"]
Apoptosis --> FTD["Frontotemporal<br/>Dementia"]

Mito_Dysfunction --> Neurodegeneration["Neurodegeneration<br/>Process"]
Autophagy --> Neurodegeneration

style BCL2L11 fill:#006494
style FOXO fill:#4a1a6b
style PTEN fill:#4a1a6b
style MAPK8 fill:#4a1a6b
style BECN1 fill:#1b5e20
style Apoptosis fill:#ef5350
style ER_Stress fill:#ef5350
style Oxidative_Stress fill:#ef5350
style Mito_Dysfunction fill:#ef53

BCL2L11 Gene

Pathway Diagram

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">BCL2L11 — BCL2 Like 11 (BIM)</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>BCL2L11</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>BCL2 Like 11 (BIM)</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>2q13</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/10018" target="_blank">10018</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000113194" target="_blank">ENSG00000113194</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/603677" target="_blank">603677</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/O43521" target="_blank">O43521</a></td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Parkinson's Disease](/diseases/parkinson), [Alzheimer's Disease](/diseases/alzheimer), [Amyotrophic Lateral Sclerosis](/diseases/als)</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Ubiquitous; high expression in neuronal tissues</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ad" style="color:#ef9a9a">AD</a>, <a href="/wiki/ali" style="color:#ef9a9a">ALI</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/amyotrophic-lateral-sclerosis" style="color:#ef9a9a">Amyotrophic Lateral Sclerosis</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">254 edges</a></td>
</tr>
</table>

BCL2L11 — BIM (BCL2-Like 11)

Overview

BCL2L11 (commonly known as BIM) is a potent pro-apoptotic BH3-only protein that belongs to the Bcl-2 family. It is a key regulator of [apoptosis](/entities/apoptosis) and plays critical roles in neuronal survival and death pathways[@a1998]. BIM has been strongly implicated in neurodegenerative diseases where excessive apoptosis contributes to neuronal loss.

Introduction

BIM is encoded by the BCL2L11 gene and is alternatively spliced to produce multiple isoforms (BIM-EL, BIM-L, BIM-S) with varying pro-apoptotic activities. The longest isoform, BIM-EL, is the most abundant and potent[@apoptosis2007].

The protein contains a BH3 domain that is essential for its pro-apoptotic function. BIM can directly activate pro-apoptotic Bax/Bak proteins or neutralize anti-apoptotic Bcl-2 proteins through BH3 binding. Unlike p53-regulated PUMA, BIM is primarily regulated at the post-translational level—it's kept in check by sequestration to the microtubule cytoskeleton through binding to dynein light chain.

BIM is a critical mediator of apoptosis induced by various cellular stresses including growth factor withdrawal, ER stress, and mitochondrial dysfunction—all processes relevant to neurodegeneration.

Role in Neurodegeneration

Parkinson's Disease

In PD:

• Dopaminergic neuron survival: BIM is required for apoptosis induced by 6-OHDA and MPTP
• [α-Synuclein](/proteins/alpha-synuclein) toxicity: α-Synuclein oligomers activate BIM-mediated apoptosis
• Neurotrophic factor withdrawal: Loss of BDNF/GF signaling leads to BIM activation

Alzheimer's Disease

In AD:

• Amyloid-β toxicity: [Aβ](/proteins/amyloid-beta) induces BIM expression and activation in [neurons](/entities/neurons)
• [Tau](/proteins/tau) pathology: Pathological tau species promote BIM activation
• Synaptic apoptosis: BIM contributes to synaptic loss in AD

Amyotrophic Lateral Sclerosis

In ALS:

• Motor neuron degeneration: BIM is activated in response to mutant SOD1 and [TDP-43](/mechanisms/tdp-43-proteinopathy)
• Glutamate excitotoxicity: Excitotoxic stress leads to BIM activation
• Therapeutic target: BIM inhibition protects motor neurons in vitro

Therapeutic Implications

Targeting BIM

• BH3 mimetics: Drugs that mimic BIM's BH3 domain to activate apoptosis in cancer (and potentially prevent excessive apoptosis in neurodegeneration)
• Kinase inhibitors: Compounds that prevent BIM phosphorylation and activation
• Gene therapy: Modulating BIM expression to protect neurons

See Also

• [Apoptosis](/mechanisms/apoptosis)
• [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction)
• [BCL2 Family](/proteins/bcl2-protein)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [BDNF](/genes/bdnf)

Background

The study of Bcl2L11 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [NCBI Gene: BCL2L11](https://www.ncbi.nlm.nih.gov/gene/10018)
• [UniProt: BIM](https://www.uniprot.org/uniprot/O43521)
• [Ensembl: BCL2L11](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000113194)
• [OMIM: BCL2L11](https://omim.org/entry/603677)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving BCL2L11 Gene discovered through SciDEX knowledge graph analysis: